GREENLEAF PETER (Chief Executive Officer) reported 1 transaction at AURINIA PHARMACEUTICALS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/23/2026ACC: 0001363683-26-000002
DirectorOfficer· Chief Executive Officer
Since Jan 2021
-100.17K
Net shares
Net seller
$1.44M
Total sold
0
Open market trades
0B · 0S
1
Total transactions
100.17K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−100.17K
Price / share
$14.40
Trade value
$1.44M
% of position
5.4%
2/20/2026
1.85M→1.74M
Total
Net shares
−100.17K
Net value
-$1.44M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/20/2026 | F · Tax Withholding | −100.17K | $14.40 | $1.44M | 5.4% | 1.85M | 1.74M |
| Total | −100.17K | -$1.44M | ||||||
Derivative Transactions0
No derivative transactions reported